New Insight into the Mechanisms of the Anti-hyperglycemic Action of Metformin

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 13, Issue 1

Abstract

Although metformin is currently one of the most frequently prescribed drugs for the treatment of type 2 diabetes, the precise mechanism of its molecular action is not fully understood. Metformin induces mild and transient inhibition of mitochondrial respiratory-chain complex I activity, resulting in the activation of adenosine monophosphate-activated protein kinase (AMPK) and suppression of hepatic gluconeogenesis. However, recent studies provide evidence that several AMPK-independent pathways may be involved in the action of metformin. The aim of this review is to summarize novel findings on the mechanisms of the anti-hyperglycemic action of metformin, with a special attention paid to AMPK-independent pathways. The results of recent studies with gut-restricted delayed-release metformin formulation demonstrating dissociation of its glucose-lowering effect from plasma exposure are also discussed. The role of the gastrointestinal tract in the action of metformin is summarized focusing on the enhanced secretion of glucagon-like peptide-1 and modulation of gut microbiota. Recent scientific evidence extends our understanding of the complex mechanisms of metformin action, points towards potential new molecular targets for the treatment of diabetes and may promote the development of new antidiabetic therapies.

Authors and Affiliations

Anna Gruszka

Keywords

Related Articles

Proteomic Biomarker Discovery: Review of the Science and Its Challenges with Clinical Samples

Proteomics is a science that facilitates global analysis of protein expression, molecular interactions and functional states of protein in a cell, organ or organism under consideration. Protein at the molecular level rep...

Possible Impact of Thyroid Dysfunction on Menstrual Cycle in HIV/TB Co-infected Females in NAUTH, Nnewi, Nigeria

Background: Thyroid dysfunction is among the commonest endocrinopathies in HIV as well as Tuberculosis infection and can pose unique consequences on women’s reproductive health. Aim of Study: The present study aimed to...

The Performance of the Finnish Diabetes Risk Score (FINDRISC) Questionaire for Screening Individuals with Undiagnosed Type 2 Diabetes and Dysglycaemia in Nigeria

Introduction: The Finnish Diabetes Risk Score (FINDRISC) questionnaire is a non-invasive, cheap, and easy to use screening tool to estimate future risk of diabetes development and detection of asymptomatic type 2 diabete...

Patient Dignity in Coronary Care: Psychometrics of the Persian Version of the Patient Dignity Inventory

Aim: The Patient Dignity Inventory (PDI) is a valid and reliable questionnaire. This questionnaire was created by Chochinov in 2002 and is used to measure various sources of distress related to the dignity of patients. T...

Association of BRCA1/2 Mutation and TP53 Over-Expression with Sporadic vs. Hereditary Iraqi Ovarian Cancer Patients

Aims: In Iraq, ovarian cancer is the fifth most common cause of death, and the 6th in the list of most common cancers. While TP53 is the most common tumor suppressor gene involved with human malignancies, ovarian cancer...

Download PDF file
  • EP ID EP340015
  • DOI 10.9734/BJMMR/2016/23354
  • Views 55
  • Downloads 0

How To Cite

Anna Gruszka (2016). New Insight into the Mechanisms of the Anti-hyperglycemic Action of Metformin. Journal of Advances in Medicine and Medical Research, 13(1), 1-9. https://europub.co.uk/articles/-A-340015